Literature DB >> 10633057

Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved.

V Venard1, A Carret, D Corsaro, P Bordigoni, A Le Faou.   

Abstract

In the Bone Marrow Transplant Unit of the "Centre Hospitalier Universitaire" in Nancy, from October 1995 to May 1996, 13 patients of 65 (20%) had a positive adenovirus (Ad) culture after bone marrow transplant. This unusually high rate raised fears of nosocomial spread and so isolates were serotyped. Fourteen Ad strains were isolated from the 13 patients, nine were of serotype 1, 2 or 3, and 5 were non-typable. These five latter strains were responsible for four cases of severe infection with fatal outcome within a two-month period. They were further submitted to restriction fragment length polymorphism analysis of their DNA which showed the isolates differed by a percentage similarity of 8-79%. In this outbreak, different strains were involved, and there was no evidence of a nosocomial origin of Ad infection. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Year:  2000        PMID: 10633057     DOI: 10.1053/jhin.1999.0656

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

1.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Adenovirus: current epidemiology and emerging approaches to prevention and treatment.

Authors:  Uriel Sandkovsky; Luciano Vargas; Diana F Florescu
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

3.  Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

Authors:  Diana F Florescu; Steven A Pergam; Michael N Neely; Fang Qiu; Christine Johnston; SingSing Way; Jane Sande; Deborah A Lewinsohn; Judith A Guzman-Cottrill; Michael L Graham; Genovefa Papanicolaou; Joanne Kurtzberg; Joseph Rigdon; Wendy Painter; Herve Mommeja-Marin; Randall Lanier; Maggie Anderson; Charles van der Horst
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

4.  Isolation and molecular characterization of Adenovirus in suspected acute flaccid paralysis patients: A preliminary report from Pakistan.

Authors:  Zainab Khattak; Aamer Ali Shah; Syed Sohail Zahoor Zaidi; Nayab Mahmood; Muhammad Masroor Alam; Salmaan Sharif; Ribqa Akhtar; Yasir Arshid; Muhammad Suleman Rana
Journal:  Arch Virol       Date:  2022-01-04       Impact factor: 2.574

Review 5.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 6.  Treatment of adenovirus infections in the immunocompromised host.

Authors:  P Ljungman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-10       Impact factor: 3.267

7.  Latent species C adenoviruses in human tonsil tissues.

Authors:  C T Garnett; G Talekar; J A Mahr; W Huang; Y Zhang; D A Ornelles; L R Gooding
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

8.  Immunocompromised Children with Severe Adenoviral Respiratory Infection.

Authors:  Joanna C Tylka; Michael C McCrory; Shira J Gertz; Jason W Custer; Michael C Spaeder
Journal:  Crit Care Res Pract       Date:  2016-05-08

9.  Unique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolates.

Authors:  Soeren Hofmayer; Ijad Madisch; Sebastian Darr; Fabienne Rehren; Albert Heim
Journal:  BMC Genomics       Date:  2009-11-25       Impact factor: 3.969

10.  Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient.

Authors:  Ravi Parasuraman; Ping L Zhang; Dilip Samarapungavan; Leslie Rocher; Alan Koffron
Journal:  Case Rep Transplant       Date:  2013-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.